HUE051557T2 - A mieloid sejtek-1 (TREM-1) TREM-szerû 1. transzkriptumon (TLT-1) expresszált receptor kiváltó eredetû peptidek gátlása és felhasználása - Google Patents

A mieloid sejtek-1 (TREM-1) TREM-szerû 1. transzkriptumon (TLT-1) expresszált receptor kiváltó eredetû peptidek gátlása és felhasználása

Info

Publication number
HUE051557T2
HUE051557T2 HUE13759234A HUE13759234A HUE051557T2 HU E051557 T2 HUE051557 T2 HU E051557T2 HU E13759234 A HUE13759234 A HU E13759234A HU E13759234 A HUE13759234 A HU E13759234A HU E051557 T2 HUE051557 T2 HU E051557T2
Authority
HU
Hungary
Prior art keywords
trem
tlt
transcript
receptor
inhibition
Prior art date
Application number
HUE13759234A
Other languages
English (en)
Hungarian (hu)
Inventor
Sebastien Gibot
Amir Boufenzer
Hafid Ait-Oufella
Marc Derive
Original Assignee
Inst Nat Sante Rech Med
Univ De Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ De Lorraine filed Critical Inst Nat Sante Rech Med
Publication of HUE051557T2 publication Critical patent/HUE051557T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE13759234A 2012-09-07 2013-09-09 A mieloid sejtek-1 (TREM-1) TREM-szerû 1. transzkriptumon (TLT-1) expresszált receptor kiváltó eredetû peptidek gátlása és felhasználása HUE051557T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12306079 2012-09-07

Publications (1)

Publication Number Publication Date
HUE051557T2 true HUE051557T2 (hu) 2021-03-01

Family

ID=46826397

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13759234A HUE051557T2 (hu) 2012-09-07 2013-09-09 A mieloid sejtek-1 (TREM-1) TREM-szerû 1. transzkriptumon (TLT-1) expresszált receptor kiváltó eredetû peptidek gátlása és felhasználása

Country Status (24)

Country Link
US (1) US9657081B2 (enExample)
EP (1) EP2892920B1 (enExample)
JP (1) JP6307080B2 (enExample)
KR (1) KR102181384B1 (enExample)
CN (1) CN104837865B (enExample)
AU (1) AU2013311606B2 (enExample)
CA (1) CA2884121C (enExample)
CY (1) CY1123014T1 (enExample)
DK (1) DK2892920T3 (enExample)
ES (1) ES2797625T3 (enExample)
HR (1) HRP20200875T8 (enExample)
HU (1) HUE051557T2 (enExample)
IL (1) IL237615B (enExample)
LT (1) LT2892920T (enExample)
MX (1) MX385794B (enExample)
NZ (1) NZ705899A (enExample)
PL (1) PL2892920T3 (enExample)
PT (1) PT2892920T (enExample)
RS (1) RS60421B1 (enExample)
RU (1) RU2672341C2 (enExample)
SI (1) SI2892920T1 (enExample)
SM (1) SMT202000309T1 (enExample)
WO (1) WO2014037565A2 (enExample)
ZA (1) ZA201501779B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
HK1254289A1 (zh) * 2015-06-12 2019-07-19 台湾基督长老教会马偕医疗财团法人马偕纪念医院 调控免疫反应的方法及抗体
US11472877B2 (en) 2016-03-04 2022-10-18 Alector Llc Anti-TREM1 antibodies and methods of use thereof
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
CA3109702A1 (en) 2018-08-13 2020-02-20 Signablok, Inc. Peptides and compositions for targeted treatment and imaging
EP4065152A1 (en) * 2019-11-25 2022-10-05 Institut National de la Santé et de la Recherche Médicale (INSERM) Trem-1 inhibitors for the treatment of vaso-occlusions and tissue injuries in patients suffering from sickle cell disease
CN116490199A (zh) * 2020-06-05 2023-07-25 伊诺特伦公司 用于治疗患有冠状病毒感染的受试者的trem-1抑制剂
CR20230025A (es) 2020-06-26 2023-10-05 Amgen Inc Muteínas de il-10 y proteínas de fusión de las mismas referencia cruzada a solicitudes relacionadas
EP4304626A1 (en) 2021-03-12 2024-01-17 Institut National de la Santé et de la Recherche Médicale (INSERM) Trem-1 inhibitors for the treatment of marfan syndrome
MX2023015442A (es) 2021-06-25 2024-03-12 Amgen Inc Tratamiento de la enfermedad cardiovascular con proteínas de unión a antígeno trem-1.
WO2025196177A1 (en) 2024-03-21 2025-09-25 Institut National de la Santé et de la Recherche Médicale Use of soluble trem-1 as a biomarker for assessing the risk of cardiovascular disease in asymptomatic subjects

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
DE69434860T2 (de) 1993-02-22 2007-03-15 The Rockefeller University Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
RO117971B1 (ro) 1994-09-12 2002-11-29 Schering Ag Procedeu de obtinere a unei proteine asp pallidipin recombinanta, proteina obtinuta si compozitie farmaceutica cu aceasta
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
IL149251A0 (en) * 2000-08-22 2002-11-10 Brigham & Womens Hospital Diagnosis and treatment of cardiovascular conditions
US20040180409A1 (en) * 2003-03-16 2004-09-16 Mcvicar Daniel TLT-1, a novel platelet-associated receptor and uses therefor
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
US7553936B2 (en) * 2006-12-04 2009-06-30 The United States of America as represented by Secretary Department of Health and Human Services Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
WO2009013319A1 (en) 2007-07-23 2009-01-29 Bioxell Spa Screening, therapy and diagnosis
DE102009018620A1 (de) 2009-04-27 2010-10-28 Carefusion Germany 234 Gmbh Ansteuer- und Auswerteschaltung, Messgerät sowie Verfahren zum Messen der Konzentration eines Gases
JP5467313B2 (ja) * 2009-09-28 2014-04-09 国立大学法人 岡山大学 アテローム動脈硬化抑制剤
HUE050815T2 (hu) 2010-04-08 2021-01-28 Inst Nat Sante Rech Med A trem-szerû 1. transzkriptumból (tlt-1) származó gátló peptidek és azok felhasználása

Also Published As

Publication number Publication date
HRP20200875T8 (hr) 2021-04-30
AU2013311606B2 (en) 2017-10-05
SMT202000309T1 (it) 2020-07-08
US9657081B2 (en) 2017-05-23
IL237615B (en) 2018-12-31
RU2015112625A (ru) 2016-10-27
CA2884121C (en) 2021-10-12
ZA201501779B (en) 2016-10-26
LT2892920T (lt) 2020-07-10
HK1212360A1 (en) 2016-06-10
KR20150110460A (ko) 2015-10-02
NZ705899A (en) 2018-08-31
MX385794B (es) 2025-03-18
CN104837865A (zh) 2015-08-12
SI2892920T1 (sl) 2020-08-31
CY1123014T1 (el) 2021-10-29
RU2672341C2 (ru) 2018-11-14
AU2013311606A1 (en) 2015-04-09
WO2014037565A2 (en) 2014-03-13
MX2015002994A (es) 2016-01-14
US20150232531A1 (en) 2015-08-20
PL2892920T3 (pl) 2020-08-24
HRP20200875T1 (hr) 2020-09-04
RS60421B1 (sr) 2020-07-31
DK2892920T3 (da) 2020-06-08
EP2892920A2 (en) 2015-07-15
JP2015533791A (ja) 2015-11-26
WO2014037565A9 (en) 2015-06-11
KR102181384B1 (ko) 2020-11-20
EP2892920B1 (en) 2020-03-04
PT2892920T (pt) 2020-06-16
ES2797625T3 (es) 2020-12-03
CA2884121A1 (en) 2014-03-13
CN104837865B (zh) 2019-09-24
WO2014037565A3 (en) 2014-05-15
IL237615A0 (en) 2015-04-30
JP6307080B2 (ja) 2018-04-04

Similar Documents

Publication Publication Date Title
HUE054444T2 (hu) Prolinnal lezárt kapcsos peptidek és felhasználásuk
HUE046396T2 (hu) Kiméra faktor VIII polipeptidek és ezek alkalmazása
EP2946339A4 (en) BIOMETRIC IMAGING DEVICES AND CORRESPONDING METHODS
HUE054881T2 (hu) Nyomtatási rendszer és eljárás
HUE036955T2 (hu) Antitestek, amelyek a trigger receptort kötik és blokkolják, amely Myeloid-sejteken-1 (TREM-1) van expresszálva
DK3929207T3 (da) Peptid fttftvt til anvendelse i behandling af fibrose
DK2552434T3 (da) Peptider og anvendelse deraf
EP2646459A4 (en) PEPTIDE STAND DESIGN
SG11201500111VA (en) Peptides and uses thereof
ZA201501779B (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
SG11201508730TA (en) Dna-binding protein using ppr motif, and use thereof
EP2883954A4 (en) PEPTID BANK AND ITS USE
ZA201601967B (en) Novel peptides and analogs for use in the treatment of oral mucositis
EP2855506A4 (en) PEPTIDE AND USE THEREOF
PL3041441T3 (pl) Orteza ręki do podtrzymywania kciuka szczególnie w przypadku rizartrozy
HUE040418T2 (hu) Antimikrobiális peptid és felhasználásai
EP2998313A4 (en) PEPTIDE FOR INDUCING MAST CELL SPECIFIC APOPTOSIS AND USE THEREOF
ZA201403474B (en) Processes and systems for separate, parallel methane and higher alkanes' bromination
EP3025953A4 (en) Small watercraft for leisure use
EP3049153B8 (de) Zyklische, amyloid-beta-bindende peptide und deren verwendung
SG11201502980VA (en) POLYPEPTIDES DERIVED FROM TGFβ AND USES THEREOF
FR3004257B1 (fr) Dispositif augmentateur de pression d'echantillonnage de gnl
IL242238B (en) Synthetic anti-inflammatory peptides and their uses
IL235836B (en) Melanoma antigenic peptide and its uses
PL2526951T3 (pl) Ramno-polisacharyd z kompleksu klonalnego 17 Enterococcus faecium i jego zastosowania